Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension: Nitric Oxide and More

被引:2
|
作者
Kim, Young Dae [1 ]
机构
[1] Dong A Univ, Dept Internal Med, Coll Med, Pusan 602715, South Korea
关键词
D O I
10.4070/kcj.2011.41.2.58
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:58 / 60
页数:3
相关论文
共 50 条
  • [1] Nitric oxide and pulmonary arterial pressures in pulmonary hypertension
    Machado, RF
    Nerkar, MVL
    Dweik, RA
    Hammel, J
    Janocha, A
    Pyle, J
    Laskowski, D
    Jennings, C
    Arroliga, AC
    Erzurum, SC
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (07) : 1010 - 1017
  • [2] Inhaled nitric oxide: a more physiological treatment or persistent pulmonary arterial hypertension in the newborn
    Thebaud, B
    Mercier, JC
    ARCHIVES DE PEDIATRIE, 1997, 4 (10): : 988 - 1003
  • [3] A Pathogenetic Paradigm for Pulmonary Arterial Hypertension
    Voelkel, Norbert F.
    Cool, Carlyne D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (10) : 967 - 968
  • [4] Toward More Individualized Treatment of Pulmonary Arterial Hypertension: Investigation of Biomarkers for Nitric Oxide Deficiency
    Klinger, James
    McMahon, Timothy
    Dweik, Raed
    Platt, David
    O'Brien, Gerald
    Satler, Carol
    CHEST, 2015, 148 (04)
  • [5] Cellular Mechanisms Underlying the Pathogenetic Role of the Primary Cilium in Pulmonary Arterial Hypertension
    Melnikov, A.
    Solymosi, P. D.
    Pennitz, P.
    Schupp, J. C.
    Nouailles, G.
    Perret, P.
    Gallo, K.
    Hegemann, N.
    Veetil, N. Nambiar
    Klepetko, W.
    Sinn, K.
    Erfinanda, L.
    Simmons, S.
    Kucherenko, M. M.
    Knosalla, C.
    Preissner, R.
    Kwapiszewska, G.
    Witzenrath, M.
    Kuebler, W. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [6] Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension
    Ghofrani, HA
    Pepke-Zaba, J
    Barbera, JA
    Channick, R
    Keogh, AM
    Gomez-Sanchez, MA
    Kneussl, M
    Grimminger, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 68S - 72S
  • [7] Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension
    Crosswhite, Patrick
    Sun, Zhongjie
    JOURNAL OF HYPERTENSION, 2010, 28 (02) : 201 - 212
  • [8] Evolution of pathogenetic therapy of pulmonary arterial hypertension
    Chazova, I. E.
    Yarovoy, S. Yu.
    Danilov, N. M.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (12) : 4 - 9
  • [9] Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
    Tettey, Abraham
    Jiang, Yujie
    Li, Xiaohui
    Li, Ying
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] Erythrocyte Derived Nitric Oxide Production in Pulmonary Arterial Hypertension
    Ulker, Pinar
    Ozen, Nur
    Basarici, Ibrahim
    Kilavuz, Ece
    Basrali, Filiz
    Koksoy, Sadi
    ACTA PHYSIOLOGICA, 2019, 227 : 27 - 27